Some people also notice an improvement in their overall sense of well-being and a reduction in symptoms associated with deficiency, such as tingling or numbness in the extremities
However, 7 cross sectional studies examining acute effects of the GLP-1-based therapies 37,38,39,40,41,42,43 found a significant increase in % FMD following GLP-1-based interventions (mean difference in the changes from baseline: 2.58 [1.68, 3.53] %
Deyo, R
This article examines the clinical considerations, potential interactions, side effects, and monitoring requirements when Wegovy and lisdexamfetamine are used together, in line with UK guidance from NICE, MHRA, and the BNF
If they differ from the instructions below, do what the packaging tells you
The logic: if they can help people stay on effective medications, they reduce long-term risk